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Abstract Tyramine b-monooxygenase (TBM) is a
member of a family of copper monooxygenases containing
two noncoupled copper centers, and includes peptidylgly-
cine monooxygenase and dopamine b-monooxygenase. In
its Cu(II) form, TBM is coordinated by two to three His
residues and one to two non-His O/N ligands consistent
with a [CuM(His)2(OH2)2–CuH(His)3(OH2)] formulation.
Reduction to the Cu(I) state causes a change in the X-ray
absorption spectroscopy (XAS) spectrum, consistent with a
change to a [CuM(His)2S(Met)–CuH(His)3] environment.
Lowering the pH to 4.0 results in a large increase in the
intensity of the Cu(I)–S extended X-ray absorption ﬁne
structure (EXAFS) component, suggesting a tighter Cu–S
bond or the coordination of an additional sulfur donor. The
XAS spectra of three variants, where the CuM Met471
residue had been mutated to His, Cys, and Asp, were
examined. Signiﬁcant differences from the wild-type
enzyme are evident in the spectra of the reduced mutants.
Although the side chains of His, Cys, and Asp are expected
to substitute for Met at the CuM site, the data showed
identical spectra for all three reduced variants, with no
evidence for coordination of residue 471. Rather, the K-
edge data suggested a modest decrease in coordination
number, whereas the EXAFS indicated an average of two
His residues at each Cu(I) center. These data highlight the
unique role of the Met residue at the CuM center, and pose
interesting questions as to why replacement by the cupro-
philic thiolate ligand leads to detectable activity whereas
replacement by imidazole generates inactive TBM.
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Abbreviations
DBM Dopamine b-monooxygenase
EXAFS Extended X-ray absorption ﬁne structure
FT Fourier transform
PHM Peptidylglycine monooxygenase
S2 Schneider 2
TBM Tyramine b-monooxygenase
Tris Tris(hydroxymethyl)aminomethane
XANES X-ray absorption near edge structure
XAS X-ray absorption spectroscopy
Introduction
Tyramine b-monooxygenase (TBM) is a member of a
small class of copper-containing monooxygenases which
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DOI 10.1007/s00775-010-0677-3utilize a pair of mononuclear copper centers at their active
sites [1–4] to catalyze the hydroxylation of benzylic or
peptidylglycyl Ca carbon atoms. Other members of the
family include dopamine b-monooxygenase (DBM; cate-
cholamine biosynthesis), peptidylglycine monooxygenase
(PHM; C-terminal peptide amidation), and monooxygenase
X (unknown function) [5]. Akin to the mammalian
enzymes DBM and PHM, TBM is associated with neuro-
transmission in invertebrates, and catalyzes the hydroxyl-
ation of tyramine to octopamine (Fig. 1b); both molecules
are critical to physiological functions, such as neuromus-
cular transmission and behavioral development, in insects
[6–8]. Whereas a signiﬁcant database of spectroscopic
information has been accumulated for these enzymes
[9–13], crystallographic characterization has only been
achieved for PHM [14, 15]. The two copper centers of the
monooxygenases (denoted CuM and CuH) are bound in a
solvent-ﬁlled cleft approximately 11 A ˚ apart, and are
structurally and spectroscopically distinct. CuM is coordi-
nated by two His residues and a Met residue, whereas CuH
is coordinated to three His residues. A structure of the
reduced enzyme co-crystallized with a slow substrate has
revealed the presence of a dioxygen molecule bound at the
CuM center, where the O–O bond length is suggestive of a
Cu(II)–superoxo complex [16]. This observation, together
with further kinetic [17, 18], biochemical [19], and theo-
retical [20] evidence, has led to the proposal that the active
oxygen species is best formulated as a Cu(II)–superoxo
species.
The Met residue at the CuM center appears to play a
critical but as yet elusive role in catalysis. Early studies on
PHM M314X substitutions reported undetectable catalytic
activity in spent medium from PHM cell lines expressing
the Ile, His, Asp, and Cys variants [21, 22]. More recent
studies using puriﬁed variants of TBM in which the
homologous Met ligand (M471) was mutated to His, Asp,
or Cys have established a dramatic decrease in activity,
with only the M471C variant displaying measurable
activity [9]. Extended X-ray absorption ﬁne structure
(EXAFS) studies on both DBM [10, 11] and PHM [12, 23,
24] have determined that the sulfur from the Met residue is
a ligand to CuM in the reduced but not the oxidized
enzyme. However, a crystal structure of the M314I mutant
of PHM revealed changes at both CuM and CuH suggestive
of a more complex role than simple copper coordination
[25]. Model studies on mononuclear Cu(II)–superoxo
complexes have in general provided limited insight into the
contribution of a coordinated thioether to oxygen activation
[26]. The thioether moiety has little effect on the reactivity
of the synthetic copper complexes. However, incorporation
of thioether into a mononuclear b-diketonate Cu(II)
superoxo species suggested complex chemistry involving
ﬂuxional Met coordination at low temperature [27, 28],
which complemented observations from EXAFS that the
PHM Cu–S(Met) bond is unusually weak, and also possibly
ﬂuxional. This led to the suggestion that the dynamics of
the Cu–S(Met) interaction in PHM may play a role in
providing a vibrational coordinate for hydrogen-atom tun-
neling during hydrogen-atom abstraction from the peptide
substrate [24].
Other explanations for the important role of the M-site
Met residue in catalysis have been advanced. It has been
suggested that the weak donor power of the Met residue
[17] prevents the copper–dioxygen complex from under-
going signiﬁcant O2 reduction prior to substrate activation
by hydrogen-atom abstraction. In essence, this effect
would shift the equilibrium for Cu(I)–dioxygen binding to
the left, by S(Met) stabilization of the Cu(I) form, thereby
inhibiting uncoupling reactions induced by superoxide or
peroxide ‘‘leakage’’ from the active site [17, 20]. A Cu(I)
stabilizing role of Met has been observed experimentally
in studies of the peroxide reactivity of PHM where
analysis of product isotopomers clearly showed an equi-
librium between Cu(II)–superoxo and Cu(I)–dioxygen
species [19]. However, despite much work, the role of the
thioether ligand in catalysis remains a major unanswered
question.
The expression of TBM in Drosophila Schneider 2 (S2)
cells [4, 29] provides a useful platform for mutagenesis
studies to further probe the role of the Met residue at CuM
in catalysis. Recently copper binding and enzymatic
activity data were reported for a series of mutants at the
M471 residue in TBM, including the Met to Cys, His, and
Asp variants [9]. As stated previously, only the Cys variant
retained measurable catalytic activity. The oxidized Cu(II)
forms of all three variants bound an equivalent amount of
copper, and showed no perturbation of their EPR spectral
properties relative to the wild-type protein. In the present
study, EXAFS measurements on these isolated TBM
mutants have allowed us to examine, for the ﬁrst time,
potential structural correlations to the altered reactivities.
Since the Met residue forms only a weak axial interaction
in the oxidized form of PHM [13, 23] and DBM [10],
major differences in copper coordination are only antici-
pated in the reduced forms. Here, we used X-ray absorption
spectroscopy (XAS) to probe the structure of the copper
centers in the wild type and each of the M471 variants, and
in particular to assess whether residue 471 is able to bind to
the reduced copper center. Changes in the Cu(I) coordi-
nation sphere of the mutant enzyme forms would have
signiﬁcant implications for the reaction of the enzyme with
dioxygen, and for the subsequent formation of relevant
intermediates. Although wild-type TBM appears to bind
M471 in a fashion similar to PHM and DBM, we ﬁnd no
spectroscopic evidence for strong interactions of His, Asp,
or Cys with the CuM center.
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Materials
Drosophila S2 cells, insect cell growth media, and Dro-
sophila Expression System were purchased from Invitro-
gen. Blasticidin was purchased from Sigma. Primers were
custom-ordered, high-performance-liquid-chromatography-
puriﬁed, from Operon. Chromatography media was
purchased from GE Healthcare. All other materials were
obtained from Sigma.
Protein expression
For the purposes of the XAS studies, wild-type and mutant
TBM lacking the His-tag were used. A stop codon was
introduced into the pBipTBM plasmid DNA for wild-type
TBMandTBMmutants[9],precedingthesequenceofbases
encoding for the rTEV recognition site and His-tag
contained in the original construct [4]. The altered
pBipTBM plasmid was transformed into Escherichia coli
strain XL1 Blue (Stratagene) cells and puriﬁed using a
QIAGEN HiSpeed plasmid midi kit. The composition of the
puriﬁed plasmid was conﬁrmed by DNA sequencing (Uni-
versity of California, Berkeley, Sequencing Facility), prior
to transfection into the S2 cells. The expression of wild-type
and mutant TBM in Drosophila S2 cells was performed
according to previously described procedures [4].
Protein puriﬁcation
All puriﬁcation steps were carried out at 277 K. The
recombinant enzyme was puriﬁed from the culture medium
as follows. The cell culture (1.5 L) was centrifuged
(3,000 rpm, 10 min) and the supernatant batch-bound to
200 mL (diethylamino)ethyl–Sepharose Fast Flow resin
(10 mM potassium phosphate, pH 8), as previously
described [4]. The column-bound protein was washed with
OH
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Fig. 1 a The H and M centers
of the mononuclear
monooxygenases modeled on
the crystal structure (Protein
Data Bank ﬁle 3PHM) of the
catalytic core of peptidylglycine
monooxygenase. b Reaction
catalyzed by tyramine b-
monooxygenase. c Modeling of
His, Asp, and Cys at residue 471
into the catalytic M-site
showing the potential for
coordination of each ligand at
the CuM center
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1232 L of equilibration buffer, and the protein was subse-
quently eluted with a buffer gradient (1 L, 10 mM to
0.25 M potassium phosphate, pH 8). Protein-containing
fractions (as determined by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis) were combined, dialyzed
overnight (10 kDa cutoff membrane) against 4 L of
tris(hydroxymethyl)aminomethane (Tris) buffer (20 mM
Tris, 50 mM NaCl, pH 7.5), concentrated to approximately
20 mL (Millipore Ultrafree centrifugal concentrators,
50 kDa cutoff membrane), and loaded onto a Q-Sepharose
column (15 mL) equilibrated with the same low-salt buffer.
The column was washed with 100 mL of the equilibration
buffer, and the protein was eluted using a NaCl gradient
(300 mL, 20 mM Tris, 0.05 M to 0.2 M NaCl; followed by
100 mL, 0.2 M to 0.5 M NaCl). The protein content of the
fractions was again determined by sodium dodecyl sulfate
polyacrylamide gel electrophoresis. The purest fractions
were combined, concentrated to less than 1 mL, and puri-
ﬁed using size-exclusion chromatography, as described
previously [4]. Single-banded fractions were combined and
used for the preparation of XAS samples.
Preparation of samples for XAS
The puriﬁed wild-type and mutant TBM samples (3–6 mg,
50 mM Tris, 0.1 M NaCl, pH 7.5) were copper-reconsti-
tuted by dialysis against a tenfold volume of the same Tris
buffer containing 40 lM CuSO4, for 6 h (10 kDa cutoff
membrane). The samples were subsequently concentrated
to 1 mL (10 kDa cutoff membrane), diluted to 5 mL with
low-copper-containing buffer (50 mM Tris, 0.1 M NaCl,
5 lM CuSO4, 24% ethylene glycol, pH 7.5), and ﬁnally
reconcentrated to a volume of less than 1 mL.
The low-pH wild-type TBM sample was prepared by
12-fold dilution of a concentrated sample at pH 7.5 with
low-pH Tris buffer (50 mM Tris, 0.1 M NaCl, 21% eth-
ylene glycol, pH 4) followed by subsequent reconcentra-
tion of the sample to a ﬁnal volume of less than 1 mL.
Reduced protein samples were prepared in an inert
atmosphere glove box. An excess of ascorbate ( more than
4.5 equiv; the ascorbate solution was 1.5 mM in deoxy-
genated water) was added to a concentrated sample of
wild-type or mutant TBM, prepared as described above,
that had been deoxygenated by sparging it with water-
saturated argon. Samples were spun down (8,000 rpm,
1 min) to remove any precipitate.
All enzyme samples for XAS contained approximately
20% ethylene glycol. Eighty microliters of each prepared
solution was added to an XAS sample holder via a syringe,
and frozen in liquid nitrogen. The ﬁnal TBM concentration
of all XAS samples ranged from 150 to 450 lM. Protein
concentrations were determined both by Bradford assays
and by UV–vis (A280) spectroscopy. Molecular weights and
extinctions coefﬁcients (A280) for wild-type and mutant
TBM lacking the His-tag were determined using ExPASy,
on the assumption that all Cys are half-Cys and neglecting
anyposttranslationalglycosylation(http://www.expasy.org).
The concentrations determined by Bradford assays were
within 5% of the values derived from the absorbance at
280 nm.
Collection and analysis of XAS data
Copper K-edge (8.9 keV) EXAFS and X-ray absorption
near edge structure (XANES) data were collected at the
Stanford Synchrotron Radiation Lightsource operating at
3 GeV with currents between 100 and 80 mA. Cu(I)-con-
taining samples were measured on beam line 9-3 using a
Si[220] monochromator and a rhodium-coated mirror
upstream of the monochromator with a 13 keV energy
cutoff to reject harmonics. A second rhodium mirror
downstream of the monochromator was used to focus the
beam. Data were collected in ﬂuorescence mode using a
high-count-rate Canberra 30-element germanium array
detector with maximum count rates below 120 kHz. A Z-1
nickel oxide ﬁlter and a Soller slit assembly were placed in
front of the detector to reduce the elastic scatter peak.
Cu(II) samples were measured on beam line 7-3 using
lower ﬂuxes and unfocused optics, but with a similar beam
line conﬁguration of monochromator and harmonic-rejec-
tion mirror. Energy calibration was achieved by reference
to the ﬁrst inﬂection point of a copper foil (8,980.3 eV)
placed between the second and third ionization chambers.
The samples (80 lL) were measured as aqueous glasses
(more than 20% ethylene glycol) at 10–15 K. Six scans of a
sample containing only sample buffer were collected,
averaged, and subtracted from the averaged data for the
protein samples to remove Z-1 Kb ﬂuorescence and pro-
duce a ﬂat pre-edge baseline. Data reduction and back-
ground subtraction were performed using the program
modules of EXAFSPAK [30]. Data from each detector
channel were inspected for glitches, dropouts, or other
nonlinear behavior before inclusion in the ﬁnal average.
Spectral simulation was carried out using the program
EXCURVE 9.2 [31–34] as previously described [23].
EXAFS data were simulated using a mixed-shell model
consisting of imidazole and S(Met) coordination. First-
shell distances (R) and Debye–Waller factors (2r
2) for the
Cu–N(imidazole) and the Cu–S(Met) shell, and the
threshold energy E0 were initially reﬁned. In these pre-
liminary reﬁnements, the imidazole ring outer-shell carbon
and nitrogen atoms were constrained to move relative to
the ﬁrst-shell Cu–N distance so as to maintain the idealized
ring geometry, and all single- and multiple-scattering
pathways were included in the calculations as previously
described [23]. Later in the reﬁnement, this constraint was
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allowed to ﬂoat within 10% of their original idealized
positions. In practice, the ﬁnal outer-shell coordinates for
acceptable ﬁts deviated by less than the permitted amount
from the idealized position. The parameters reﬁned in the
ﬁt included shell occupancy N, copper-scatterer distance R,
and Debye–Waller factor (2r
2) for each shell, and the
threshold energy (E0) for photoelectron ionization, which
was constrained to be the same for all shells of scatterers.
Results
XAS of the wild-type enzyme
Previous studies of copper loading to TBM showed that the
enzyme bound 1.9 coppers per protein [9] and sequence
homology between TBM and PHM with respect to copper-
binding residues suggests these two copper centers are
chemically distinct. Since X-ray absorption detects only the
average ligand environment, chemical modeling is required
to gain information speciﬁc to each site. In a previous
EXAFS study of PHM, we used the information from the
crystal structure to generate a model which reﬁned the two
copper centers independently [23], the accuracy of which
was later conﬁrmed by Chen et al. [13] using geometry
optimization of the crystal coordinates by density func-
tional theory calculations. In the present case, we applied
similar methods. The data were ﬁt initially by an average
coordination over both copper centers, and were subse-
quently tested for improvements in goodness of ﬁt (F)
when the copper centers were modeled separately. Figure 2
compares the Fourier transforms (FT) and EXAFS spectra
for the oxidized and reduced forms of TBM. The oxidized
form shows a spectrum typical of Cu(II)–imidazole coor-
dination as expected from His ligation. The data ﬁt well to
2.5 His residues and 1.5 O/N ligands, which represent the
average coordination at each copper. No improvement in
the value of F was obtained by modeling the coppers
individually. The EXAFS spectrum of reduced TBM dif-
fers signiﬁcantly from that of the oxidized protein, showing
a large decrease in amplitude of the ﬁrst shell in the FT. A
single shell of imidazole groups was generally sufﬁcient to
account for the EXAFS and transform features. Figure 2
also shows the ﬁt of reduced TBM at pH 7.0, corresponding
to two His residues with Cu–N distances of 1.94 A ˚ and 0.5
sulfur at 2.24 A ˚ (Table 1, reduced protein ﬁt A). The
Debye–Waller term for the Cu–N(His) shell is unusually
large and suggests a large spread in the individual
Cu–N(His) distances. This suggested the presence of two
coordinatively distinct copper centers, and in this case
warranted further exploration of chemical inequivalence
between the copper centers. This was achieved by
assuming inequivalence of the His coordination at each
copper, and simulating the data with two independent
shells of imidazole ligands. Splitting the imidazole scat-
tering into two separate contributions produced no
improvement in the value of the goodness-of-ﬁt parameter
F, but resulted in more reasonable values for the Debye–
Waller factors of each shell (Table 1, reduced protein ﬁt B,
Fig. S1). Notably, one shell of His residues appears to be at
a short distance of 1.88 A ˚, a distance typical of two-
coordinate Cu(I)–imidazole complexes [35–37], whereas
the other shell reﬁnes to R = 1.98 A ˚, a distance more
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Fig. 2 Phase-corrected Fourier transforms and extended X-ray
absorption ﬁne structure (EXAFS) (upper insets) for oxidized (top)
and ascorbate-reduced (bottom) copper centers in tyramine b-
monooxygenase. Solid black lines are experimental data and dashed
red lines are simulations using parameters listed in Table 1. The
lower insets show the X-ray absorption near edge structure (XANES)
region of the spectrum
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123characteristic of three-coordinate Cu(I). We assign the
two- and three-coordinate sites to the H-site and M-site,
respectively.
We also explored ﬁts involving higher imidazole coor-
dination numbers, since homology to PHM predicts that all
ﬁve His residues could remain coordinated to Cu(I) in the
reduced form, leading to the predicted average imidazole
per copper of 2.5 [14, 15, 23]. Fits using a single shell of
2.5 His per copper gave acceptable F values but with even
larger Cu–N Debye–Waller factors (2r
2 = 0.022 A ˚ 2,
Table 1, reduced protein ﬁt C). Using the above reasoning,
this implies more heterogeneity between the two Cu(I)
centers, but unexpectedly, two-shell ﬁts with increased
coordination number resulted in extremely poor ﬁts to the
data, with an unacceptably larger Debye–Waller factor at
one copper center. The conclusion that we draw from this
analysis is that the Cu(I) centers are most likely each
coordinated by only two EXAFS-detectable His ligands.
However, given the difﬁculty in determining EXAFS-
derived coordination numbers to high precision, the
presence of a third His residue at the CuH center cannot be
discounted.
The identity of the remaining ligands at the M-site is
less clear from the EXAFS data. Inclusion of a weak-
interaction 0.5 sulfur donor at 2.24 A ˚ improves the ﬁt by
broadening the ﬁrst shell in the FT sufﬁciently to ﬁt the
experimental data. However, the Debye–Waller factor is
unusually high for an isolated absorber–scatterer interac-
tion, and suggests there may be two or more conformations
for the Met ligand. Metal-S(Met) coordination often exists
as multiple conformers with the terminal methyl group of
one rotated relative to the other [38]. The best ﬁt to the data
is listed in Table 1, ﬁt A. Figure S1 compares ﬁts using one
versus two groups of imidazoles, while Figure S2 shows
the effect of ommitting the sulfur ligation.
pH dependence of the reduced wild-type protein
PHM shows a pH-dependent structural transition in which
the intensity of the Cu–S interaction increases with
Table 1 Fits obtained to the extended X-ray absorption ﬁne structure of reduced tyramine b-monooxygenase and its Met to His, Asp, and Cys
variants
Cu–N(His)
a Cu–O/N Cu–S/Cl -E0
F
b No.
c R (A ˚)
d DW (A ˚ 2) No.
c R (A ˚)
d DW (A ˚ 2) No.
c R (A ˚)
d DW (A ˚ 2)
Oxidized proteins
WT pH 7 0.520 2.5 1.97
e 0.012 1.5 1.97
e 0.012 4.35
M471H 0.470 2.5 1.97
e 0.012 1.5 1.97
e 0.012 4.98
M471D 0.513 2.5 1.96
e 0.012 1.5 1.96
e 0.012 4.35
M471C 0.410 2.5 1.97
e 0.011 1.5 1.97
e 0.011 4.98
Cu–N(His1)
a Cu–N(His2)
a Cu–S/Cl
Reduced proteins
WT pH 7 (ﬁt A) 0.328 2 1.94 0.016 0.5 2.24 0.015 2.28
WT pH 7 (ﬁt B) 0.324 1 1.88 0.012 1 1.98 0.007 0.5 2.25 0.014 2.10
WT pH7 (ﬁt C) 0.342 2.5 1.95 0.022 0.5 2.24 0.014 2.28
WT pH 4 0.857
f 2 1.94 0.017 1 2.28 0.012 1.88
M471H 0.358 2 1.91 0.011 2.1
M471D 0.359 2 1.91 0.009 1.94
M471C 0.681 2 1.92 0.012 1.93
DW Debye–Waller factor, WT wild type
a Fits modeled His coordination by an imidazole ring, which included single- and multiple-scattering contributions from the second-shell (C2/
C5) and third-shell (C3/N4) atoms, respectively. The Cu–N–Cx angles were as follows: Cu–N–C2 126, Cu–N–C3 -126, Cu–N–N4 163, Cu–
N–C5 -163
b F is a least-squares ﬁtting parameter deﬁned as F
2 ¼ 1
N
PN
i¼1 k
6ðData   ModelÞ
2
c Coordination numbers are generally considered accurate to ±25%
d In any one ﬁt, the statistical error in bond lengths is ±0.005 A ˚. However, when errors due to imperfect background subtraction, phase-shift
calculations, and noise in the data are compounded, the actual error is probably closer to ±0.02 A ˚
e The distances of the Cu–N(His) and Cu–N/O (non-His) shells were constrained to be equal
f The larger value of the goodness-of-ﬁt parameter results from data of lower signal to noise
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123decreasing pH with a pK of approximately 4.6 in 2-mor-
pholinoethanesulfonic acid buffer [24]. Given the homol-
ogy between PHM and TBM, it was of interest to
determine whether a similar structural transition was
present in TBM. Figure 3 compares the FTs of reduced
TBM at pH 4 and pH 7, whence it can be seen that the
intensity of the Cu–S peak at R * 2.3 increases dramati-
cally at pH 4. Figure 3 also shows a simulation of the low-
pH data with two Cu–N(His) interactions at 1.94 A ˚ and one
Cu–S/Cl interaction at 2.28 A ˚. The increase in shell
occupancy from 0.5 to one Cu–S/Cl suggests that an
additional Cu–S/Cl interaction is observed at low pH but
the correlation between shell occupancy and the Debye–
Waller factor implies that the alternative of a more rigid
(lower Debye–Waller factor) Cu–S interaction should also
be considered. In the PHM system the increase in Cu–S
intensity at low pH could be simulated either by an addi-
tional Cu–S interaction or by allowing the Debye–Waller
factor to decrease at low pH, and it was argued that the
latter would imply a transition from a ﬂexible to a rigid
conformation [24]. The pK for the transition correlated
with the decrease in activity at low pH, and it was sug-
gested that the active form of the enzyme therefore
required a ﬂexible conformation with a weak or ﬂuxional
Cu–S(Met) interaction at CuM. In contrast, the TBM low-
pH data cannot be adequately simulated with 0.5 Cu–S and
a low Debye–Waller factor. Furthermore, the bond length
for the Cu–S/Cl interaction increases from 2.24 A ˚ at pH 7
to 2.28 A ˚ at pH 4. This increase in bond length is incon-
sistent with a strengthening of the Cu–S bond which is
implied by a lower Debye–Waller factor, and suggests that
the increased intensity more likely arises from an addi-
tional Cu–S/Cl ligation at one of the copper centers at low
pH.
Met to His, Cys, and Asp variants
To probe the role of the essential Met residue at position
471 in TBM, variants with His, Cys, or Asp replacing the
Met were created. Figure 4 compares the spectra of all
three mutants with those of the wild-type protein for the
oxidized proteins. Remarkably, the agreement among all
four experimental spectra is closer than that between the
spectrum of the wild type and its best simulation. There-
fore, we conclude that there is no difference in coordina-
tion between the wild type and the M471X variants,
proving conclusively that residue 471 does not coordinate
the CuM(II) center of the oxidized protein in a manner
detectable by EXAFS spectroscopy. The spectra of the
reduced variants differ signiﬁcantly from the spectrum of
the wild-type reduced protein (Fig. 5, top), but are all
similar to each other (Fig. 5, bottom), suggesting that
replacement of the M-site residue by His, Cys, or Asp
produces a species with similar coordinate structure. All
three reduced variants can be well ﬁt by an average of two
His residues at each copper with Cu–N(His) distances of
1.91 ± 0.01 A ˚ (Fig. 6, Table 1). As expected, the His and
Asp variants show no sign of Cu–S interactions. However,
since the Cys variant exhibits small differences from His
and Asp in the k = 7–9 A ˚ -1 energy regime, we tested
whether these arose from a Cu–S contribution of low shell
occupancy, perhaps arising from a small population of
enzyme molecules in a ‘‘Cys-on’’ conformation. When the
Cu–S Debye–Waller factor was ﬁxed at 0.005 A ˚ ´ 2, a value
typical of Cu(I)–thiolate bonds, the simulations could tol-
erate 14% of a Cu–S conformation, with RCu–S = 2.28 A ˚ ´.
However, the goodness of ﬁt was not improved in these
simulations, and the inclusion of the Cu–S wave did not
account for the small differences in EXAFS between
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123k = 7A ˚ -1 and k = 9A ˚ -1. Therefore, the major species
present in all three variants contains only Cu–His coordi-
nation, but we cannot exclude the possibility of a minor
component in M471C having coordinated Cys, which
might possibly account for the observed activity of this
variant. Figure 6 compares experimental and simulated
EXAFS spectra for the His and Cys variants. Simulation
using a two-shell imidazole model resulted in one group of
Cu–His interactions at a short distance of approximately
1.84 A ˚ and a second group at a longer distance of
approximately 1.95 A ˚. The separation of 0.11 A ˚ is below
the limit of resolution of the experiment given by DR =
p/2Dk equal to 0.15 A ˚. These distances suggest one two-
coordinate and one three-coordinate site, respectively.
Absorption edges
XANES spectra for wild-type TBM and the M471 variants
are shown in Fig. 7 (top). Wild type oxidized and reduced
spectra are compared in Fig. 7 (top). These are typical for
this class of copper monooxygenases, with the oxidized
absorption edge shifted about 7 eV relative to the reduced
protein with a low-intensity 1s ? 3d transition at
8,979 eV, and weak unresolved features on the rising edge
at 8,983.5 and 8,988 eV. The reduced protein exhibits a
resolved feature at 8,983.4 which can be assigned as the
1s ? 4p transition of Cu(I) in a three-coordinate envi-
ronment [37, 39, 40]. All of these XANES features
resemble those of PHM [23] and DBM [10], and conﬁrm
the similarity in coordinate structure of the copper centers
of this class of copper monooxygenases.
Figure 7 (bottom) compares XANES spectra for the
reduced wild-type protein and the three M471 mutant
proteins. The M471 variants also show the 1s ? 4p tran-
sition but it is more intense and shifted slightly to higher
energy (8,984.0 eV). Of particular interest is the almost
exact coincidence of the XANES spectra for all three M471
variants, reinforcing the conclusion from EXAFS analysis
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123that they all have very similar coordination at both copper
centers. The increased intensity indicates that the average
coordination number has decreased, and is consistent with
the observed decrease in the Cu–N(His) distance, which
drops from 1.94 A ˚ in the reduced wild type to 1.91 A ˚ in the
mutant proteins. In general, Cu(I)–N(His) distances corre-
late with the coordination number, with the distance
decreasing as the coordination number drops. The decrease
in coordination can be explained by assuming that residue
471 no longer coordinates at the M-site, and that the latter
is coordinated by just two His residues. Alternatively, the
loss of M471 may also induce changes at the H-site as
recently observed in the crystal structure of the M314I
mutant of PHM [25].
Discussion
TBM shares structural features with PHM and DHM.
Sequence alignment (Fig. 8) shows that all the residues
known to be involved in copper binding in PHM are con-
served in TBM, and suggests that TBM likewise contains a
pair of mononuclear copper centers bound by H247, H248,
and H317 (H-site) and H396, H398, and M471 (M-site).
However, kinetic studies with TBM have revealed several
important differences between the mechanism of the insect
enzyme and the established mechanism of the mammalian
homologues, with respect to the interaction of the enzymes
with substrate and ascorbate [29]. We used XAS to
investigate the coordination environment of the copper
centers of TBM with the purpose of understanding the
structural origins of these mechanistic differences. Data on
the oxidized and reduced forms of the wild-type protein
bear a close resemblance to those from PHM establishing a
homology with respect to copper binding. Thus, we con-
clude that in oxidized TBM Cu(II) is bound by three His
residues and a water molecule at the H-site, and by two His
R (Å)
-1)
2 4 6 8 10 12
-5
0
5
123456
F
o
u
r
i
e
r
 
T
r
a
n
s
f
o
r
m
0
10
20
KeV
8.98 9.00
0.0
0.5
1.0
Met to His
R (Å)
k (Å
k (Å-1)
2 4 6 8 10 12
-5
0
5
123456
F
o
u
r
i
e
r
 
T
r
a
n
s
f
o
r
m
0
10
20
KeV
8.98 9.00
0.0
0.5
1.0
Met to Cys
Fig. 6 Phase-corrected Fourier transforms and EXAFS (upper insets)
for reduced M471 to His (top) and reduced M471 to Cys (bottom)
variants of tyramine b-monooxygenase. Solid black lines are exper-
imental data and dashed red lines are simulations using parameters
listed in Table 1. The lower insets show the XANES region of the
spectrum
keV
8970 8980 8990 9000
F
/
I
0
0.0
0.5
1.0
WT 
His 
Cys 
Asp  
keV
8970 8980 8990 9000
F
/
I
0
0.0
0.5
1.0
Oxidized
Reduced
Fig. 7 Comparison of XANES of the copper centers of tyramine
b-monooxygenase. Top: Oxidized versus reduced wild-type proteins.
Bottom: Reduced proteins: WT black, Met to His blue, Met to Cys
red, Met to Asp green
J Biol Inorg Chem (2010) 15:1195–1207 1203
123residues and two solvent molecules at the M-site. On
reduction, the solvent coordination is lost, and M471
moves closer to CuM to form a three-coordinate center
comprising H396, H398, and M471. Although the EXAFS
data are best ﬁt to two His residues at each copper site, the
similarity of the spectra to previous data on reduced wild-
type PHM and DBM, and the additional crystallographic
information available for PHM, supports a three-coordinate
CuH site, with one weakly bound His residue undetectable
by EXAFS. Thus, loss of solvent at the H-site appears to
result in a three-coordinate Cu(I) center in the reduced
form of wild-type TBM, bound by H247, H248, and H317.
Thus, mechanistic differences among the three enzymes do
not appear to result from an altered copper coordination
environment in TBM.
The pH dependence of the EXAFS spectrum of reduced
wild-type TBM shows an increase in intensity of the Cu–S
interaction similar to that reported previously for PHM but
with important differences [24]. Although the pKa for the
pH transition was not determined, it is likely that a similar
Met-on to Met-off transition controls the catalytic activity
of TBM at low pH. In PHM, the Met-off form was shown
to be catalytically active, whereas the Met-on form was
inactive, and it was proposed that Met-off represented the
weakly bound, ﬂuxional CuM–S(Met) form fully described
by EXAFS and crystallography. It was proposed [24] that
Met ﬂuxionality provided the necessary protein dynamics
to bring the enzyme into the transient conﬁguration critical
for hydrogen tunneling. The identity of the Met-on form is
less clear, but two possibilities exist: (1) a rigid, strongly
bound CuM–S(Met) lacking in some essential ﬂuxional
component necessary for catalysis, or (2) a Cu–S interac-
tion formed between either a copper center and a different
sulfur-containing residue or, alternatively, reaction of one
of the copper centers with an exogenous chloride ion. The
fact that TBM low-pH data ﬁt better to one Cu–S/Cl per
TBM with a longer bond length yet smaller Debye–Waller
factor is suggestive of the latter conclusion. All of the ten
Cys residues in PHM are present as disulﬁdes and it is
therefore unlikely that additional Cu–S coordination
involves a Cu(I)–Cys(thiolate) interaction. However, the
strong preference of Cu(I) centers for Met coordination, for
example in the periplasmic copper binding proteins CusF
[38], CusB [41], pcoC [42], and CopK [43], indicates that a
Met residue is a likely candidate. PHM and TBM share
only two conserved Met residues, the catalytic-site M314/
M471 residue and M109/M249, which is contiguous to the
H-site copper-binding His residues, but is rotated away
from the copper on the opposite side of the b-sheet. If the
Met-on form represents copper coordination by a different
Met residue, then CuH coordination to M109/M249 seems
a likely option. This would require a signiﬁcant confor-
mational change induced by protonation of an as yet
unassigned residue. The resultant loss of activity could be
the result of a change in reduction potential of the H-site
expected if a Met residue replaces a His residue. Alterna-
tively, the reorientation of b-structure required to bring
M109/M249 into coordinating distance of the CuH center
would most likely disrupt the hydrogen bond between
H108 and E170 (numbering refers to PHM) which has been
proposed as part of the putative substrate-mediated electron
transfer pathway between the two copper centers [15].
Fig. 8 Sequence alignment
using Clustal W 2.0.10 of
members of the family of
mononuclear monooxygenases.
Sequences for peptidylglycine
monooxygenase (PHM) and
dopamine b-monooxygenase
(DBM) are from rat, for
tyramine b-monooxygenase
(TBM) are from Drosophila
melanogaster, and for
monooxygenase X (MOX) are
from human. Metal-binding
residues and conserved Met
residues are shown in red
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123The possibility that the additional interaction is due to
binding of exogenous chloride at low pH cannot be
excluded on the basis of EXAFS analysis, but seems less
likely from a chemical perspective. There is no reason why
chloride binding should be pH-dependent as HCl is a
strong acid. Additionally, similar chemistry has recently
been observed with PHM in samples which do not contain
chloride ion [24]. Therefore, although we cannot exclude
chloride, coordination by M249 seems the most likely
option.
The unique coordination of the copper centers has been
shown in PHM and DBM to induce novel monooxygenase
chemistry. In these sister proteins, catalysis begins by
coordination of an oxygen molecule at the reduced
mononuclear CuM center as observed crystallographically
in a precatalytic complex with a slow substrate [16]. The
O–O bond length in this complex is consistent with a
Cu(II)–superoxo species, and dovetails with other bio-
chemical [17, 19] and theoretical [3, 20] studies that
implicate Cu(II)–O2
 - as the reactive oxygen intermediate.
The electrophilic nature of such an intermediate is expected
to lead to efﬁcient hydrogen-atom abstraction from an a-
carbon of peptide substrate [44] or the benzylic position of
phenethylamines, and calculations suggest a preference for
side-on superoxide coordination [3, 20]. However, among
the growing number of mononuclear Cu(II)–superoxo
model complexes [26], only two are reactive toward
hydrocarbon substrates [45, 46], and these exhibit end-on
superoxo coordination. A more common reactivity of
mononuclear Cu(II)–superoxo species is dimerization with
another molecule of the Cu(I) parent complex to generate
the dinuclear Cu(II)–peroxo complex. The large spatial
separation of the copper centers in PHM and by analogy
TBM prevents this chemistry, and thus allows the potent
electrophilic reactivity of the mononuclear Cu(II)–superoxo
species to be fully expressed in the form of hydrogen-atom
abstraction from the substrate to form a [CuM(II)-OOH]
(peroxo) intermediate. Subsequent steps in the reaction
pathway are less clear and alternative mechanisms have
been proposed that involve long-range electron transfer
from CuH either before [17] or after [20] the transfer of an
OH group to the substrate radical.
An unresolved issue relating to this mechanism is the
role of the M-site Met residue in stimulating catalysis. As
stated earlier, the ﬂexibility of the Met ligand has been
invoked as a necessary element for catalysis. In addition,
the Met ligand is believed to inﬂuence the Cu(II)/(I) redox
equilibrium at the CuM site [17] and thus affect the extent
of dioxygen activation. A preference for formation of an
initial Cu(I)–O2 versus a Cu(II)–superoxide species is
thought to stem from the effect of sulfur ligation. This
equilibrium shift in favor of an unactivated bound dioxy-
gen species would greatly reduce uncoupling and the
formation of harmful reactive oxygen species, prior to C–H
activation. The alternative residues Asp, His, and Cys, in
place of the Met ligand at CuM, were thus chosen to further
examine the signiﬁcance of this residue.
Mutation of M471 in TBM to His, Asp, or Cys resulted
in a large decrease in activity, with only the M471C variant
displaying measurable activity, albeit coincident with
enzyme inactivation [9]. In the case of PHM, the M314X
variants had no detectable activity in assays of spent media
from Chinese hamster ovary cell overexpression [21, 22].
One of the goals of the present work was to provide a
structural basis for the reduction/loss in catalytic activity
by examining the EXAFS-derived structures of the M471X
(X is His, Cys, Asp) variants. Results on the oxidized
protein establish that the Met ligand does not bind strongly
to the Cu(II)M center, as no Cu–S interaction is observed.
This result is similar to those for PHM and DBM, where no
Cu–S EXAFS interaction is seen in the Cu(II) form [10,
23], owing to a long axial Cu–S(Met) interaction [13], and
leads to the prediction that His and Asp would likewise
bind axially and be undetectable by EXAFS, as is observed
experimentally. The Cys variant might have been expected
to show some properties of type 1 copper centers due to the
N2S coordination, but it too appears to produce no per-
turbation on the wild-type spectrum with no observable
thiolate-to-Cu(II) charge transfer. The EXAFS results
together with earlier EPR data [9] therefore suggest that the
oxidized CuM site accommodates all four side chains
without signiﬁcant structural rearrangement.
In contrast, the reduced forms of wild-type and variant
TBM show signiﬁcant differences. At pHs at or above the
activity maximum (pH 5.5–6), reduced wild-type TBM
exhibits a Cu–S interaction equivalent to 0.5 Cu–S at
2.25 A ˚ with a Debye–Waller factor (2r
2 = 0.015 A ˚ 2)
which is high for a strongly coordinated ligand, and may
suggest some ﬂuxional behavior involving either multiple
Met conformations (as is seen, for example, in the peri-
plasmic chaperone CusF [38]), or alternatively rapid
coordination and dissociation of the thioether moiety.
Such behavior has been observed in Cu(I)NXS(thioether)
models of the CuM site including pendant thioether con-
taining b-diketiminate Cu(I) complexes which show
temperature-dependent changes in the thioether-bonded
methylene proton NMR resonances [28], and in TMPA-
derived (TMPA = tris(2-pyridylmethyl)amine) N3S(thio-
ether) models where the thioether arm is easily displaced
by CO [47]. Cu–S(Met) ﬂuxionality may be an important
feature of the M active site, either to provide facile
conversion to axially coordinated Cu(II)–S(Met) upon
oxygen binding and formation of the Cu(II)–superoxo
intermediate [13], or to provide kinematic coupling to a
normal mode critical to hydrogen tunneling during the
hydrogen-atom abstraction step [1, 24, 48].
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Cys variants with EXAFS data for reduced wild-type
TBM shows differences, but analysis leads to the con-
clusion that none of these substitutions lead to detectable
coordination to copper. The presence of both CuH and
CuM makes it difﬁcult to isolate the structural changes at
the M-site, and the data give only the average change at
both coppers. However, since the H-site locus is
unchanged in these variants, it is reasonable to assume
that the observed structural changes derive mainly from
the M-site substitutions. Analysis of the EXAFS data
gives a similar structure for all three variants, with loss of
the Cu–S component, and decrease in the residual two
Cu–N(His) bond lengths. In parallel, the XANES data
shows an increase in intensity of the 8,983-eV edge fea-
ture. These changes are consistent with a decrease in
coordination number and suggest a simple interpretation
that the M-site becomes two-coordinate. Although coor-
dination of oxygen-donor groups, such as Asp, is less
common among copper proteins, it is surprising that
neither His nor Cys seems capable of signiﬁcant binding
to CuM. The ﬂuxional Cu(I)–Met interaction, and its
movement by some 0.5 A ˚ on copper oxidation indicates
the absence of steric restrictions in the site, and modeling
conﬁrms this conclusion (Fig. 1c). In other systems, Met
to His substitution appears quite facile, for example, the
M121H variant of Alcaligenes denitriﬁcans azurin, where
despite the ‘‘rack-induced’’ rigidity of the cupredoxin
fold, H121 moves closer to the copper and becomes a
fourth strongly bound ligand [49]. Likewise, recent work
from one of the authors’ laboratories (N.J.B.) has dem-
onstrated Met coordination in the H135 to Met substitu-
tions of Bacillus subtilis Sco (unpublished).
The crystal structure of the PHM M314I variant sug-
gests one possible reason for the failure of the alternative
His or Cys residues to coordinate [25]. Here the CuM site in
oxidized M314I PHM accommodates the mutation by
replacing M314Sc with a water molecule, and by shifting
the positions of the other coordinating residues (H242,
H244, and a water molecule), to form a distorted tetrahe-
dron. I314 is rotated away from the copper in a different
conformation. Interestingly the PHM M314I structure also
shows signiﬁcant perturbation at the H-site. H107 and
H172 are now linearly coordinated with H108 dissociated.
The M471X substitutions in TBM may favor this altered
conformation. Therefore, one hypothesis for the essential
role of Met at the M-site is that it uniquely stabilizes the
protein in its catalytic conformation in addition to, or
instead of, electronic tuning of the reactivity of the Cu(II)–
superoxo [17] and/or the Cu(II)–oxyl intermediates [20]a s
previously proposed.
This does not, however, explain the singular activity of
the M471C TBM mutant. The lack of sulfur-atom
coordination by the Cys residue to CuM(I) does not pre-
clude substrate turnover. The observed activity of the
M471C mutant may arise from a small population of
enzyme in a Cys-bound conformation, which is not
inconsistent with the EXAFS analysis. Low occupancy of
the Cys-bound form could also provide an explanation for
the inactivation of M471C TBM during the reaction with
substrate. According to the current hypothesis, the ﬂuxional
dynamics of the Cu–Met bond prevent uncoupling of
dioxygen and C–H activation during the catalytic cycle.
Since a fully liganded Cys may be expected to modulate
the chemistry at the CuM site as efﬁciently as the Met
ligand, the inactivation of M471C via oxidative damage
(R.L. Osborne and J.P. Klinman, unpublished data) may
be a direct consequence of its poor coordination to the
reduced metal. Further work is needed to evaluate these
aspects.
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